MetaCap

Corcept Therapeutics Insider Trades

NASDAQ: CORTHealth CareBiotechnology: Pharmaceutical PreparationsUSD

121.19+2.65 (+2.24%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
0 · $0
Sales
56 · $52.80M
Shares bought / sold
0 / 454.75K
Net activity
Net selling $52.8 million

Corcept Therapeutics insider activity

Over the last 12 months, Corcept Therapeutics insiders reported 100 transactions on SEC Form 4: 0 open-market purchases and 56 sales. Insiders bought $0 and sold $52.8 million worth of stock, for net insider selling of $52.8 million. The largest seller was Maduck Sean, with $12.5 million in reported sales.

The most recent filing shows Vieira Roberto Wandenkolk (President, Oncology) reporting a transaction in 8,333 shares at $21.63 on Oct 2, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put CORT's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

CORT insider transactions

Corcept Therapeutics insider transactions
DateInsiderTypeSharesValueFiling
Oct 2, 2026Lyon Joseph DouglasSee RemarksSale4,744$552.87KForm 4
Oct 2, 2026Lyon Joseph DouglasSee RemarksSale4,446$514.39KForm 4
Oct 2, 2026Lyon Joseph DouglasSee RemarksOption exercise5,833$112.34KForm 4
Oct 2, 2026Lyon Joseph DouglasSee RemarksOption exercise3,357$45.52KForm 4
Oct 2, 2026Maduck SeanSee RemarksSale8,744$1.02MForm 4
Oct 2, 2026Maduck SeanSee RemarksSale15,843$1.84MForm 4
Oct 2, 2026Maduck SeanSee RemarksOption exercise24,587$203.33KForm 4
Oct 2, 2026Vieira Roberto WandenkolkPresident, OncologySale5,147$600.06KForm 4
Oct 2, 2026Vieira Roberto WandenkolkPresident, OncologySale2,086$241.41KForm 4
Oct 2, 2026Vieira Roberto WandenkolkPresident, OncologySale1,100$125.97KForm 4
Oct 2, 2026Vieira Roberto WandenkolkPresident, OncologyOption exercise8,333$180.24KForm 4
Oct 1, 2026Lyon Joseph DouglasSee RemarksSale810$93.47KForm 4
Oct 1, 2026Lyon Joseph DouglasSee RemarksOption exercise810$10.98KForm 4
Oct 1, 2026Maduck SeanSee RemarksSale413$47.72KForm 4
Oct 1, 2026Maduck SeanSee RemarksOption exercise413$3.42KForm 4
Sep 24, 2026Robb Gary CharlesChief Business OfficerGift5,000—Form 4
Sep 24, 2026Robb Gary CharlesChief Business OfficerGift5,000—Form 4
Sep 24, 2026Robb Gary CharlesChief Business OfficerGift17,100—Form 4
Sep 17, 2026Robb Gary CharlesChief Business OfficerOption exercise17,493$144.67KForm 4
Sep 16, 2026Vieira Roberto WandenkolkPresident, OncologySale296$29.84KForm 4
Sep 15, 2026WILSON JAMES NDirectorSale2,800$312.77KForm 4
Sep 15, 2026WILSON JAMES NDirectorSale400$44.33KForm 4
Sep 15, 2026WILSON JAMES NDirectorSale6,800$749.83KForm 4
Sep 14, 2026Lyon Joseph DouglasSee RemarksSale2,188$249.69KForm 4
Sep 14, 2026Lyon Joseph DouglasSee RemarksSale7,812$885.26KForm 4
Sep 14, 2026Lyon Joseph DouglasSee RemarksOption exercise7,404$100.40KForm 4
Sep 14, 2026Lyon Joseph DouglasSee RemarksOption exercise2,596$29.46KForm 4
Sep 2, 2026Mokari AtabakChief Financial OfficerTax withholding102$11.56KForm 4
Sep 2, 2026Robb Gary CharlesChief Business OfficerTax withholding91$10.32KForm 4
Sep 2, 2026Maduck SeanSee RemarksTax withholding117$13.27KForm 4
Sep 2, 2026Lyon Joseph DouglasSee RemarksTax withholding72$8.16KForm 4
Sep 2, 2026Vieira Roberto WandenkolkPresident, OncologySale1,225$141.41KForm 4
Sep 2, 2026Vieira Roberto WandenkolkPresident, OncologySale5,621$644.04KForm 4
Sep 2, 2026Vieira Roberto WandenkolkPresident, OncologySale1,606$182.63KForm 4
Sep 2, 2026Vieira Roberto WandenkolkPresident, OncologySale974$109.47KForm 4
Sep 2, 2026Vieira Roberto WandenkolkPresident, OncologySale1,537$171.18KForm 4
Sep 2, 2026Vieira Roberto WandenkolkPresident, OncologySale23,770$2.63MForm 4
Sep 2, 2026Vieira Roberto WandenkolkPresident, OncologySale23,600$2.58MForm 4
Sep 2, 2026Vieira Roberto WandenkolkPresident, OncologyOption exercise58,333$1.26MForm 4
Sep 2, 2026Vieira Roberto WandenkolkPresident, OncologyTax withholding102$11.56KForm 4
Sep 1, 2026Mokari AtabakChief Financial OfficerAward138—Form 4
Sep 1, 2026Mokari AtabakChief Financial OfficerAward138$15.65KForm 4
Sep 1, 2026Robb Gary CharlesChief Business OfficerAward164—Form 4
Sep 1, 2026Robb Gary CharlesChief Business OfficerAward164$18.59KForm 4
Sep 1, 2026Maduck SeanSee RemarksAward150—Form 4
Sep 1, 2026Maduck SeanSee RemarksAward150$17.01KForm 4
Sep 1, 2026Maduck SeanSee RemarksSale2,281$263.71KForm 4
Sep 1, 2026Maduck SeanSee RemarksSale10,989$1.26MForm 4
Sep 1, 2026Maduck SeanSee RemarksSale11,730$1.34MForm 4
Sep 1, 2026Maduck SeanSee RemarksOption exercise25,000$206.75KForm 4
Sep 1, 2026Lyon Joseph DouglasSee RemarksAward130—Form 4
Sep 1, 2026Lyon Joseph DouglasSee RemarksAward130$14.74KForm 4
Sep 1, 2026Vieira Roberto WandenkolkPresident, OncologyAward138—Form 4
Sep 1, 2026Vieira Roberto WandenkolkPresident, OncologyAward138$15.65KForm 4
Sep 1, 2026Guyer WilliamChief Development OfficerAward164—Form 4
Sep 1, 2026Guyer WilliamChief Development OfficerAward164$18.59KForm 4
Aug 26, 2026Park KimberlyDirectorSale26,685$3.27MForm 4
Aug 26, 2026Park KimberlyDirectorTax withholding3,315$404.73KForm 4
Aug 26, 2026Park KimberlyDirectorOption exercise30,000$404.70KForm 4
Aug 25, 2026Maduck SeanSee RemarksSale5,870$739.97KForm 4
Aug 25, 2026Maduck SeanSee RemarksSale25,085$3.15MForm 4
Aug 25, 2026Maduck SeanSee RemarksOption exercise30,955$351.34KForm 4
Aug 18, 2026MAHONEY DAVID LDirectorSale400$47.86KForm 4
Aug 18, 2026MAHONEY DAVID LDirectorSale7,055$838.71KForm 4
Aug 18, 2026MAHONEY DAVID LDirectorSale91,167$10.78MForm 4
Aug 18, 2026MAHONEY DAVID LDirectorSale4,984$585.48KForm 4
Aug 17, 2026Robb Gary CharlesChief Business OfficerSale10,000$1.16MForm 4
Aug 17, 2026Robb Gary CharlesChief Business OfficerGift125—Form 4
Aug 14, 2026WILSON JAMES NDirectorSale2,279$256.71KForm 4
Aug 14, 2026WILSON JAMES NDirectorSale4,668$520.21KForm 4
Aug 14, 2026WILSON JAMES NDirectorSale3,053$337.34KForm 4
Aug 14, 2026Maduck SeanSee RemarksSale3,664$419.49KForm 4
Aug 14, 2026Maduck SeanSee RemarksOption exercise3,664$30.30KForm 4
Aug 12, 2026Robb Gary CharlesChief Business OfficerGift3,000—Form 4
Aug 12, 2026Robb Gary CharlesChief Business OfficerGift3,000—Form 4
Aug 12, 2026Robb Gary CharlesChief Business OfficerGift11,530—Form 4
Aug 10, 2026Guyer WilliamChief Development OfficerSale4,770$543.96KForm 4
Aug 10, 2026Guyer WilliamChief Development OfficerSale11,530$1.30MForm 4
Aug 10, 2026Guyer WilliamChief Development OfficerOption exercise16,300$352.89KForm 4
Aug 10, 2026Maduck SeanSee RemarksSale1,031$118.07KForm 4
Aug 10, 2026Maduck SeanSee RemarksOption exercise1,031$8.53KForm 4
Aug 4, 2026Guyer WilliamChief Development OfficerSale3,700$418.56KForm 4
Aug 4, 2026Guyer WilliamChief Development OfficerOption exercise3,700$80.11KForm 4
Aug 3, 2026Lyon Joseph DouglasSee RemarksSale1,540$175.81KForm 4
Aug 3, 2026Maduck SeanSee RemarksSale20,305$2.33MForm 4
Aug 3, 2026Maduck SeanSee RemarksOption exercise20,305$167.92KForm 4
Jul 30, 2026Mokari AtabakChief Financial OfficerSale1,001$120.80KForm 4
Jul 30, 2026Mokari AtabakChief Financial OfficerSale8,103$971.94KForm 4
Jul 30, 2026Mokari AtabakChief Financial OfficerSale4,783$567.91KForm 4
Jul 30, 2026Mokari AtabakChief Financial OfficerSale8,267$974.95KForm 4
Jul 30, 2026Mokari AtabakChief Financial OfficerSale7,089$829.10KForm 4
Jul 30, 2026Mokari AtabakChief Financial OfficerSale14,222$1.65MForm 4
Jul 30, 2026Mokari AtabakChief Financial OfficerSale15,477$1.78MForm 4
Jul 30, 2026Mokari AtabakChief Financial OfficerSale4,700$531.94KForm 4
Jul 30, 2026Mokari AtabakChief Financial OfficerSale600$66.57KForm 4
Jul 30, 2026Mokari AtabakChief Financial OfficerSale2,202$242.28KForm 4
Jul 30, 2026Mokari AtabakChief Financial OfficerSale400$43.38KForm 4
Jul 30, 2026Mokari AtabakChief Financial OfficerSale8,956$957.89KForm 4
Jul 30, 2026Mokari AtabakChief Financial OfficerSale4,200$443.25KForm 4
Jul 30, 2026Mokari AtabakChief Financial OfficerOption exercise80,000$1.84MForm 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related